Ventana Medical Systems Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ventana Medical Systems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013174
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pathology, dermatopathology, hematopathology and prostate pathology. The company offers detection systems such as ultraVIEW SISH Detection Kit, ISH iVIEW Blue Plus detection kit, ultraView Red ISH DIG detection kit and ultraView SISH DNP detection kit.VMS also offers technical and application support services. The company markets its products through its channel of network distributors. VMS is headquartered in Tucson, Arizona, the US.

Ventana Medical Systems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ventana Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ventana Medical Enters into Agreement with Astellas Pharma to Develop Novel Automated Tissue Diagnostics 11
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 12
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 13
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab 14
Ventana Medical Systems Enters Into Co-Promotion Agreement With Advanced Cell Diagnostics 15
Ventana Medical Systems Inc – Key Competitors 16
Ventana Medical Systems Inc – Key Employees 17
Ventana Medical Systems Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ventana Medical Systems Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ventana Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ventana Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ventana Medical Enters into Agreement with Astellas Pharma to Develop Novel Automated Tissue Diagnostics 11
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 12
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 13
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab 14
Ventana Medical Systems Enters Into Co-Promotion Agreement With Advanced Cell Diagnostics 15
Ventana Medical Systems Inc, Key Competitors 16
Ventana Medical Systems Inc, Key Employees 17
Ventana Medical Systems Inc, Subsidiaries 18

★海外企業調査レポート[Ventana Medical Systems Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Welltower Inc
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AdvanDx Inc-医療機器分野:企業M&A・提携分析
    Summary AdvanDx Inc (AdvanDx), a subsidiary of OpGen Inc is a healthcare solution provider that offers rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. The company operates molecular testing of positive blood cultures …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Alberta Health Services:企業の戦略的SWOT分析
    Alberta Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Metalfrio Solutions SA:企業の戦略・SWOT・財務情報
    Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report Summary Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cyclopharm Ltd (CYC)-医療機器分野:企業M&A・提携分析
    Summary Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company’s products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and posi …
  • Etam Developpement SCA:企業の戦略・SWOT・財務情報
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Steris PLC:企業の戦略・SWOT・財務情報
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Redington (India) Limited (REDINGTON):企業の財務・戦略的SWOT分析
    Redington (India) Limited (REDINGTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務情報
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Orchard Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Orchard Therapeutics Ltd (Orchard) is an integrated commercial-stage biotechnology company that develops gene therapies for the treatment of serious and life-threatening orphan diseases. Its pipeline products include Strimvelis, an autologous ex vivo gammaretroviral gene therapy for the trea …
  • Fossil Group, Inc. (FOSL):企業の財務・戦略的SWOT分析
    Fossil Group, Inc. (FOSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Medpace Inc (MEDP):企業の財務・戦略的SWOT分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization provides services such as medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial manage …
  • Union des Groupements d’Achats Publics:企業の戦略的SWOT分析
    Union des Groupements d'Achats Publics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • National Oilwell Varco Inc (NOV)-石油・ガス分野:企業M&A・提携分析
    Summary National Oilwell Varco, Inc. (NOV) designs, manufactures and services a broad range of drilling and well servicing equipment and components for the oil and gas sector. Its offerings include rig systems, wellbore technologies, and completion and production technologies. Its product line compr …
  • Pt Bumi Resources Tbk:企業の戦略・SWOT・財務分析
    Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Resonance Health Ltd (RHT):医療機器:M&Aディール及び事業提携情報
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • Navamedic ASA (NAVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. …
  • Red River Valley Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • National Industrialization Co (2060):企業の財務・戦略的SWOT分析
    National Industrialization Co (2060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆